Cargando…

The Area Deprivation Index: A novel tool for harmonizable risk assessment in Alzheimer's disease research

INTRODUCTION: Residence in a disadvantaged neighborhood associates with adverse health exposures and outcomes, and may increase risk for cognitive impairment and dementia. Utilization of a publicly available, geocoded disadvantage metric could facilitate efficient integration of social determinants...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuelsdorff, Megan, Larson, Jamie L., Hunt, Jack F. V., Kim, Alice J., Koscik, Rebecca L., Buckingham, William R., Gleason, Carey E., Johnson, Sterling C., Asthana, Sanjay, Rissman, Robert A., Bendlin, Barbara B., Kind, Amy J. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293995/ https://www.ncbi.nlm.nih.gov/pubmed/32548238 http://dx.doi.org/10.1002/trc2.12039

Ejemplares similares

Psychological well-being and cognitive aging in Black, Native American, and White Alzheimer’s Disease Research Center participants
por: Wyman, Mary F., et al.
Publicado: (2022)

Alzheimer's disease biomarkers in Black and non‐Hispanic White cohorts: A contextualized review of the evidence
por: Gleason, Carey E., et al.
Publicado: (2021)

Association of Neighborhood-Level Disadvantage With Alzheimer Disease Neuropathology
por: Powell, W. Ryan, et al.
Publicado: (2020)

Cognitive variability—A marker for incident MCI and AD: An analysis for the Alzheimer's Disease Neuroimaging Initiative
por: Anderson, Eric D., et al.
Publicado: (2016)

Association of Neighborhood-Level Disadvantage With Neurofibrillary Tangles on Neuropathological Tissue Assessment
por: Powell, W. Ryan, et al.
Publicado: (2022)

Crosswalk study on blood collection‐tube types for Alzheimer's disease biomarkers
por: Jonaitis, Erin M., et al.
Publicado: (2022)

The application of a workflow integrating the variable reproducibility and harmonizability of radiomic features on a phantom dataset
por: Ibrahim, Abdalla, et al.
Publicado: (2021)

Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum
por: Allison, Samantha L., et al.
Publicado: (2019)

HarmonizR enables data harmonization across independent proteomic datasets with appropriate handling of missing values
por: Voß, Hannah, et al.
Publicado: (2022)

Associations between self-reported sleep patterns and health, cognition and amyloid measures: results from the Wisconsin Registry for Alzheimer’s Prevention
por: Du, Lianlian, et al.
Publicado: (2023)

Measurement batch differences and between‐batch conversion of Alzheimer's disease cerebrospinal fluid biomarker values
por: Ma, Yue, et al.
Publicado: (2021)

Predictors of Willingness to Enroll in Hypothetical Alzheimer Disease Biomarker Studies that Disclose Personal Results
por: Erickson, Claire M., et al.
Publicado: (2022)

Factors Associated with Lumbar Puncture Participation in Alzheimer’s Disease Research
por: Blazel, Madeleine M., et al.
Publicado: (2020)

The relationship of insulin resistance and diabetes to tau PET SUVR in middle-aged to older adults
por: Ennis, Gilda E., et al.
Publicado: (2023)

Self-reported health behaviors and longitudinal cognitive performance in late middle age: Results from the Wisconsin Registry for Alzheimer’s Prevention
por: Mueller, Kimberly D., et al.
Publicado: (2020)

A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E ε4 allele
por: Haasl, Ryan J, et al.
Publicado: (2008)

Recruitment and retention of underrepresented populations in Alzheimer's disease research: A systematic review
por: Gilmore-Bykovskyi, Andrea L., et al.
Publicado: (2019)

The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions
por: Johnson, Sterling C., et al.
Publicado: (2017)

Moderate intensity physical activity associates with CSF biomarkers in a cohort at risk for Alzheimer's disease
por: Law, Lena L., et al.
Publicado: (2018)

Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: A multi-resolution graph analysis
por: Kim, Won Hwa, et al.
Publicado: (2018)

Amyloid burden, cortical thickness, and cognitive function in the Wisconsin Registry for Alzheimer's Prevention
por: Doherty, Benjamin M., et al.
Publicado: (2015)

Research Participant Interest in Alzheimer’s Disease Biomarker Disclosure
por: Erickson, Claire, et al.
Publicado: (2020)

Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer’s disease
por: Miners, James, et al.
Publicado: (2023)

Gut microbiome alterations in Alzheimer’s disease
por: Vogt, Nicholas M., et al.
Publicado: (2017)

Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer's disease in non‐demented adults
por: Ennis, Gilda E., et al.
Publicado: (2021)

The Wisconsin Alzheimer's Institute Dementia Diagnostic Clinic Network: A community of practice to improve dementia care
por: Mora Pinzon, Maria, et al.
Publicado: (2022)

Microstructural white matter alterations in preclinical Alzheimer’s disease detected using free water elimination diffusion tensor imaging
por: Hoy, Andrew R., et al.
Publicado: (2017)

The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease
por: Vogt, Nicholas M., et al.
Publicado: (2018)

An Examination of Brain Abnormalities and Mobility in Individuals with Mild Cognitive Impairment and Alzheimer's Disease
por: Fischer, Barbara L., et al.
Publicado: (2017)

An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum
por: Van Hulle, Carol, et al.
Publicado: (2020)

Subjective memory complaints, cortical thinning, and cognitive dysfunction in middle-age adults at risk of AD
por: Schultz, Stephanie A., et al.
Publicado: (2015)

Extracellular vesicle biomarkers of Alzheimer's disease associated with sub‐clinical cognitive decline in late middle age
por: Eren, Erden, et al.
Publicado: (2020)

Validity Evidence for the Research Category, “Cognitively Unimpaired – Declining,” as a Risk Marker for Mild Cognitive Impairment and Alzheimer’s Disease
por: Langhough Koscik, Rebecca, et al.
Publicado: (2021)

CSF T-Tau/Aβ(42) Predicts White Matter Microstructure in Healthy Adults at Risk for Alzheimer’s Disease
por: Bendlin, Barbara B., et al.
Publicado: (2012)

Age-related differences in white matter microstructure measured by advanced diffusion MRI in healthy older adults at risk for Alzheimer’s disease
por: Motovylyak, Alice, et al.
Publicado: (2022)

Declines in Connected Language Are Associated with Very Early Mild Cognitive Impairment: Results from the Wisconsin Registry for Alzheimer’s Prevention
por: Mueller, Kimberly D., et al.
Publicado: (2018)

Meeting physical activity recommendations may be protective against temporal lobe atrophy in older adults at risk for Alzheimer's disease
por: Dougherty, Ryan J., et al.
Publicado: (2016)

Cardiorespiratory Fitness Associates with Cerebral Vessel Pulsatility in a Cohort Enriched with Risk for Alzheimer’s Disease
por: Maxa, Kaitlin M., et al.
Publicado: (2020)

Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know
por: Erickson, Claire M., et al.
Publicado: (2021)

Intracranial arterial four-dimensional flow is associated with metrics of brain health and Alzheimer's disease
por: Berman, Sara E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8744qb57khcbbupfhrmi9376bq